Search Results - "STEMPEL, Michelle"

Do Calcifications Seen on Mammography After Neoadjuvant Chemotherapy for Breast Cancer Always Need to Be Excised? by Feliciano, Yara, Mamtani, Anita, Morrow, Monica, Stempel, Michelle M., Patil, Sujata, Jochelson, Maxine S.

“…Background This study aimed to determine the relationship between mammographic calcifications and magnetic resonance imaging (MRI) tumoral enhancement before…”
Get full text

Clinical Management Factors Contribute to the Decision for Contralateral Prophylactic Mastectomy by KING, Tari A, SAKR, Rita, PATIL, Sujata, GUREVICH, Inga, STEMPEL, Michelle, SAMPSON, Michelle, MORROW, Monica

“…To determine whether increasing rates of contralateral prophylactic mastectomy (CPM) are due to recognition of risk factors for contralateral breast cancer…”
Get full text

Are there patients with T1 to T2, lymph node‐negative breast cancer who are “high‐risk” for locoregional disease recurrence? by Mamtani, Anita, Patil, Sujata, Stempel, Michelle M., Morrow, Monica

“…BACKGROUND Indications for postmastectomy radiotherapy (PMRT) in patients with T1 to T2, lymph node‐negative (N0) breast cancer with “high‐risk” features are…”
Get full text

Do LORIS Trial Eligibility Criteria Identify a Ductal Carcinoma In Situ Patient Population at Low Risk of Upgrade to Invasive Carcinoma? by Pilewskie, Melissa, Stempel, Michelle, Rosenfeld, Hope, Eaton, Anne, Van Zee, Kimberly J., Morrow, Monica

“…Background The Surgery Versus Active Monitoring for Low-Risk DCIS (LORIS) trial is studying the safety of monitoring core-biopsy diagnosed low-risk ductal…”
Get full text

Is Preoperative Axillary Imaging Beneficial in Identifying Clinically Node-Negative Patients Requiring Axillary Lymph Node Dissection? by Pilewskie, Melissa, MD, Jochelson, Maxine, MD, Gooch, Jessica C., MD, Patil, Sujata, PhD, Stempel, Michelle, MPH, Morrow, Monica, MD, FACS

“…Background American College of Surgeons Oncology Group (ACOSOG) Z0011 results support the omission of axillary lymph node dissection (ALND) in women with less…”
Get full text

Presenting Features of Breast Cancer Differ by Molecular Subtype by Wiechmann, Lisa, Sampson, Michelle, Stempel, Michelle, Jacks, Lindsay M., Patil, Sujata M., King, Tari, Morrow, Monica

“…Background Gene expression profiling of breast cancers identifies distinct molecular subtypes that affect prognosis. Our goal was to determine whether…”
Get full text

Estimating the OncotypeDX score: validation of an inexpensive estimation tool by Eaton, Anne A., Pesce, Catherine E., Murphy, James O., Stempel, Michelle M., Patil, Sujata M., Brogi, Edi, Hudis, Clifford A., El-Tamer, Mahmoud

“…Background OncotypeDX, a multi-gene expression assay, has been incorporated into clinical practice as a prognostic and predictive tool. However, its use in…”
Get full text

Late Axillary Recurrence After Negative Sentinel Lymph Node Biopsy is Uncommon by Matsen, Cindy, Villegas, Kristine, Eaton, Anne, Stempel, Michelle, Manning, Aidan, Cody, Hiram S., Morrow, Monica, Heerdt, Alexandra

“…Background This study was designed to determine the incidence of late axillary recurrence (AR) in patients with negative sentinel lymph node biopsy (SLNB) and…”
Get full text

A 10-Year Trend Analysis of Sentinel Lymph Node Frozen Section and Completion Axillary Dissection for Breast Cancer: Are These Procedures Becoming Obsolete? by Weber, Walter P., Barry, Mitchel, Stempel, Michelle M., Junqueira, Manuela J., Eaton, Anne A., Patil, Sujata M., Morrow, Monica, Cody, Hiram S.

“…Background Recent results from the ACOSOG Z0011 trial question the use of intraoperative frozen section (FS) during sentinel lymph node (SLN) biopsy and the…”
Get full text

Impact of Breast Density on the Presenting Features of Malignancy by Arora, Nimmi, King, Tari A., Jacks, Lindsay M., Stempel, Michelle M., Patil, Sujata, Morris, Elizabeth, Morrow, Monica

“…Purpose To determine the relationship between breast density, presenting features and molecular subtype of cancer, and surgical treatment received. Methods…”
Get full text

Reoperative Sentinel Lymph Node Biopsy after Previous Mastectomy by Karam, Amer, MD, Stempel, Michelle, BS, Cody, Hiram S., MD, FACS, Port, Elisa R., MD, FACS

“…Background Sentinel lymph node (SLN) biopsy is the standard of care for axillary staging in breast cancer, but many clinical scenarios questioning the validity…”
Get full text

Surgical management of the axilla: do intramammary nodes matter? by Pugliese, Matthew S., M.D, Stempel, Michelle M., M.P.H, Cody, Hiram S., M.D, Morrow, Monica, M.D, Gemignani, Mary L., M.D

“…Abstract Background The therapeutic significance of intramammary lymph nodes is uncertain. The purpose of this study was to identify the appropriate surgical…”
Get full text

Eighteen sensations after breast cancer surgery: a 5-year comparison of sentinel lymph node biopsy and axillary lymph node dissection by Baron, Roberta H, Fey, Jane V, Borgen, Patrick I, Stempel, Michelle M, Hardick, Kathleen R, Van Zee, Kimberly J

“…The aim of this study is to evaluate prevalence, severity, and level of distress of 18 sensations at baseline (3-15 days) and 5 years after breast cancer…”
Get full text

Predictors of Completion Axillary Lymph Node Dissection in Patients With Immunohistochemical Metastases to the Sentinel Lymph Node in Breast Cancer by Pugliese, Matthew S., Karam, Amer K., Hsu, Meier, Stempel, Michelle M., Patil, Sujata M., Ho, Alice Y., Traina, Tiffany A., Van Zee, Kimberly J., Cody, Hiram S., Morrow, Monica, Gemignani, Mary L.

“…Background Axillary lymph node dissection (ALND) in patients with immunohistochemistry (IHC)-determined metastases to the sentinel lymph node (SLN) is…”
Get full text

The clinical impact and outcomes of immunohistochemistry-only metastasis in breast cancer by Pugliese, Matthew, M.D, Stempel, Michelle, M.P.H, Patil, Sujata, Ph.D, Hsu, Meier, B.A, Ho, Alice, M.D, Traina, Tiffany, M.D, Morrow, Monica, M.D, Cody, Hiram, M.D, Gemignani, Mary L., M.D

“…Abstract Background Modern surgical and pathological techniques can detect small-volume axillary metastases in breast cancer with unknown clinical…”
Get full text

Determinants of outcome in elderly patients with positive sentinel lymph nodes by Karam, Amer K., M.D, Hsu, Meier, M.S, Patil, Sujata, Ph.D, Stempel, Michelle, M.S, Traina, Tiffany A., M.D, Ho, Alice Y., M.D, Cody, Hiram S., M.D, Morrow, Monica, M.D, Gemignani, Mary L., M.D., M.P.H

“…Abstract Background Older women are less likely to receive standard of care treatment for breast cancer. Methods We examined variables that affected the…”
Get full text

Model constraints on the opening rates of bands on Europa by Stempel, Michelle M., Barr, Amy C., Pappalardo, Robert T.

“…A mid-ocean-ridge spreading analog is used to constrain the opening rates and brittle–ductile transition depths for two axisymmetric ridged bands on Europa…”
Get full text

Educational Posters to Reduce Antibiotic Use by Ashe, David, Patrick, Patricia A., Stempel, Michelle M., Shi, Qiuhu, Brand, Donald A.

“…Antibiotic overuse promotes resistant strains of bacteria and puts patients at risk for adverse reactions. Given the use of educational posters in…”
Get full text

A Comparison of Patient-Reported Outcomes After Nipple-Sparing Mastectomy and Conventional Mastectomy with Reconstruction by Romanoff, Anya, Zabor, Emily C., Stempel, Michelle, Sacchini, Virgilio, Pusic, Andrea, Morrow, Monica

“…Introduction Nipple-sparing mastectomy (NSM) is increasingly used for breast cancer risk reduction and treatment. Prior small studies with variable control for…”
Get full text

Estrogen Receptor, Progesterone Receptor, and HER2 Status Predict Lymphovascular Invasion and Lymph Node Involvement by Ugras, Stacy, Stempel, Michelle, Patil, Sujata, Morrow, Monica

“…Background The ACOSOG Z0011 trial demonstrated that axillary dissection (ALND) is not necessary for local control or survival in women with T1/2cN0 cancer…”
Get full text